On April 25, a major event in the field of reproductive health took place — the conference “Genetic Initiative: Reproduction — Pregnancy Loss.” The event became one of the key professional platforms of the year, bringing together physicians, geneticists, and laboratory diagnostics specialists.
The conference was organized by the Ukrainian Society of Human Genetics (USHG), a professional community uniting leading experts in medical genetics and promoting the implementation of modern genetic technologies into clinical practice. By combining scientific expertise with practical experience, the organization creates a platform for professional dialogue, evidence-based medicine development, and in-depth analysis of genetic factors influencing reproductive health.
The main goal of the initiative was to create a space for dialogue and knowledge exchange on the topic of pregnancy loss. During the event, experts discussed the causes of early pregnancy loss, new risk markers, and practical patient management algorithms, where genetic testing becomes the foundation for successful outcomes.
The conference featured 13 leading speakers, including Andrii Aleksandrov, PhD in Biology and Head of the Molecular Genetics Research Department at Empirica Medical Company.
In his presentation, he focused on modern approaches to genetic screening that help identify risks before they become clinical reality. Particular attention was given to the following tools:
-
NIPT and PGT-A — for highly accurate prenatal and preimplantation diagnostics;
-
OGM, TGS, and newborn screening — innovative methods transforming approaches to pregnancy planning and management.
Innovative Solutions from Global Leaders
Empirica Medical Company continues introducing technologies that set global standards into Ukrainian healthcare. During the event, the company presented solutions from leading manufacturers including Revvity, Bionano, PacBio, and ImmunolVD.
These systems significantly improve the accuracy, speed, and efficiency of diagnostics, providing clinicians with greater confidence even in the most complex clinical cases.
Participation in Genetic Initiative became another important step for Empirica Medical Company in strengthening the expert medical community. The collaboration between specialists from different fields during the conference contributes to advancing medical practice and improving treatment outcomes for thousands of families.
Empirica Medical Company — delivering precision where it matters most.